Our goal is to help a million Australians quit smoking by 2021
To free the world from the senseless and avoidable global epidemic caused by smoking. We will accomplish this by creating great products that people love to use, to the highest safety standards, to create a better tomorrow.
To provide the safest and most effective eHealth services and life enhancing products possible, and to ensure they are easily accessible and affordable to all consumers. To become the global market leader in our industry with a respected household name brand that is trusted by consumers, endorsed by doctors, and accepted by regulators.
WHO WE ARE
We are a revolutionary eHealth platform provider, and are proudly an independent New Zealand owned and operated electronic cigarette device and pharmaceutical manufacturer. We offer a convenient online medical prescription service in collaboration with leading Australian tobacco treatment specialist doctors, and are the only supplier servicing the general retail sector who has met the strict quality manufacturing standards required to obtain full product liability insurance coverage in the Australasian region.
Nicovape is the only certified e-cigarette provider currently available in Australia which is produced in an ISO5 and GMP certified laboratory using only the highest grade of certified raw ingredients. Even though e-cigarette liquids and devices are not yet regulated under Australian law, our laboratory located in San Francisco, USA meets all FDA standards, and places product quality and user safety as our highest priority. We have absolutely no affiliation with any Big Tobacco corporation.
Nicovape shares the concerns of Australia’s public health community about stalled smoking rates and youth cigarette adoption. We’re determined to help improve smoking cessation rates nationwide, whilst complying with all relevant laws and regulations.
We will continue to work alongside Australian Medical Practitioners and tobacco treatment specialists in collaboration with leading scientists and industry leaders to ensure that we stay at the very forefront of electronic cigarette technology & innovation.
OUR PRESCRIPTION PROCESS & YOUTH PREVENTION STRATEGY
A regulatory requirement under the Personal Importation of Therapeutic Goods Scheme for anyone wishing to legally import or use an electronic cigarette which contains nicotine for therapeutic purposes, is that they possess a prescription for the product from a registered Australian medical practitioner.
In cooperation with a number of leading Australian doctors and tobacco treatment specialists, we have developed our proprietary eHealth platform which utilises a comprehensive online medical questionnaire to assess a patient’s suitability for an iNRT (inhaled nicotine replacement therapy) prescription.
Prior to a prescription being issued, the patient is required to enter their government issued identification details, which we verify against the governments Document Verification Service (DVS). If the patient’s details are successfully verified, and their online medical questionnaire assessment is deemed suitable for a prescribed iNRT product, one of our cooperating doctors will then issue a prescription which is delivered as a PDF via email direct to the patient.
By incorporating stringent identity verification processes as a required component in our sales process, we are able to ensure with absolute certainty that our products are only received by patients who meet the minimum legal age requirements to obtain electronic cigarette products, and who have also been medically assessed to be suitable for by a registered doctor. Our delivery process requires that all prescribed products only be released under signature, and sighting Identification which proves the recipient meets the minimum legal age requirements.